SPPAM
Summit Partners Public Asset Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.4M | Buy |
+130,000
| New | +$22.4M | 0.57% | 37 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 68 |
|
|
2024
Q4 | – | Sell |
-55,101
| Closed | -$8.23M | – | 77 |
|
|
2024
Q3 | $8.23M | Sell |
55,101
-178,572
| -76% | -$26.7M | 0.25% | 51 |
|
|
2024
Q2 | $31.9M | Buy |
233,673
+8,562
| +4% | +$1.17M | 1.22% | 29 |
|
|
2024
Q1 | $34M | Buy |
+225,111
| New | +$34M | 1.17% | 24 |
|
|
2023
Q2 | – | Sell |
-169,693
| Closed | -$18.2M | – | 74 |
|
|
2023
Q1 | $18.2M | Sell |
169,693
-3,058
| -2% | -$328K | 0.75% | 40 |
|
|
2022
Q4 | $21.1M | Buy |
+172,751
| New | +$21.1M | 1.33% | 29 |
|
|
2022
Q2 | – | Sell |
-58,651
| Closed | -$6.88M | – | 71 |
|
|
2022
Q1 | $6.88M | Buy |
+58,651
| New | +$6.88M | 0.24% | 51 |
|